CALA

Calithera Biosciences, Inc
CALA

Overview Fund Activity
Delisted

CALA was delisted on the 1st of February, 2023.

Back to rankings

22 hedge funds and large institutions have $5.02M invested in Calithera Biosciences, Inc in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 7 closing their positions.

Holders
22
Holders Change
-6
Holders Change %
-21.43%
% of All Funds
0.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
9
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$415K
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$59K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$337K
4
BNP Paribas Financial Markets
4
BNP Paribas Financial Markets
France
$3.55K
5
Bank of America
5
Bank of America
North Carolina
$2K

Top Sellers

1
Alyeska Investment Group
1
Alyeska Investment Group
Illinois
$0
2
Two Sigma Investments
2
Two Sigma Investments
New York
$0
3
VF
3
Virtu Financial
New York
$0
4
TRCT
4
Tower Research Capital (TRC)
New York
$8K
5
Citadel Advisors
5
Citadel Advisors
Florida
$587K
Name Market Value Shares Shares
Change 		Shares
Change %
LC
26
Lindbrook Capital
California
– – -500 Closed
Citigroup
27
Citigroup
New York
$0 14 -459 -97%
TC
28
Truvestments Capital
Florida
$0 52 -12 -19%
CFGS
29
Concourse Financial Group Securities
Alabama
– – – –
QC
30
Quent Capital
New York
$0 2 – –
AIM
31
Axiom Investment Management
New York
$0 250 +250 New
1
2